top of page

Are Fingersticks Over? Needle-Free Glucose Sensors Are Finally Here

Writer: Michelle Ryan, MHA
Michelle Ryan, MHA
6 minutes ago
5 min read
Close-up of a forearm wearing a coin-sized patch with a soft blue LED. A kitchen table blurs behind it, with a bowl of oatmeal and a coffee mug.

A forearm patch with a color-coded light is changing how people with type 2 diabetes monitor their glucose.


Fingersticks are painful, easy to skip, and tell you little. A needle-free sensor you can read at a glance could change how many with type 2 diabetes track daily habits.


Takeaways


  • Shine is the first needle-free CGM.

  • It shows colors, not glucose numbers.

  • Cleared for over-the-counter use, no insulin.

  • Dual glucose-ketone sensing is now FDA-authorized.

  • Ask your clinician before switching.


Needle-Free Glucose Sensors Are Finally Here


Lancet. Strip. Squeeze. Wince.


If you have type 2 diabetes, you know the ritual. Now picture glancing at your forearm instead and seeing a small light change color. That’s the idea behind Biolinq Shine. It’s real, it’s cleared, and it comes with fine print I think you should read before you get excited.


A Patch That Talks in Colors


In September 2025, the FDA granted De Novo classification to Biolinq Shine, the first wearable glucose biosensor that doesn’t need a needle for placement. De Novo is the route for brand-new device types with nothing to compare against.


So what’s actually different? Standard continuous glucose monitors use a thin filament placed with an introducer needle. Shine uses a microsensor array that sits up to 20 times shallower and skips the introducer entirely. Think of reading the top page of a book instead of digging into the chapter.


A Patch That Talks in Colors: Labeled depth diagram (conventional filament vs. microsensor array, marked “illustrative”). Photo of the patch on a forearm, credited to Biolinq’s press kit with permission.

The patch is about the size of a quarter and is worn on the forearm for five-day stretches. A built-in LED does the talking. Blue means in range, yellow means high. You don’t need a phone for that, though the app adds activity and sleep trends.


Colors, Not Numbers


Here’s the catch, and I’d rather you hear it from me. Shine doesn’t give numerical readings or alarms. The FDA also framed it as a qualitative view of ranges and trends, not a source of the exact figures used to calculate insulin doses. If you take insulin, this isn’t your device.


So why does a color matter at all? The American Diabetes Association points to time in range, staying inside your target zone at least 70% of the time. That’s hard to hit when you test now and then. A light you can glance at turns glucose from a snapshot into a movie.


Here’s a composite example, not a real patient. Daniel, 56, manages type 2 diabetes without insulin and checks once each morning. He eats pasta on Tuesday and feels fine. With a glanceable patch, he might spot yellow a couple of hours later. Thursday, same meal, plus a ten-minute walk. Blue. That’s a lesson a morning check will never teach him.


Cleared Over the Counter, Price Still Unknown


In late September 2026, Biolinq announced 510(k) clearance for over-the-counter use for adults 22 and older who don’t use insulin. No prescription needed. I couldn’t find a published price or launch date in the coverage I reviewed. Cleared, in other words, but not yet on your shelf.


From my policy seat, that’s a mixed picture. Skipping the prescription lowers the barrier to entry. It also means many people will start without a clinician in the room. A color is easy to read. What to do about it isn’t.


So if you try one, bring your trends to your next appointment. And ask three things first. Does this fit my medications? What pattern should make me call? How will my care team see the data?


What Comes Next: Ketones and Beyond


Needle-free isn’t the only frontier. In August 2026, Abbott received De Novo authorization for Libre Duo 10 Day, the first system to track glucose and ketones together. Ketones matter because diabetic ketoacidosis (DKA) can build fast, and early signs get mistaken for the flu. Glucose is the weather report. Ketones are the smoke detector.


Don’t mix the two devices up. Libre Duo is cleared for people age 2 and older with type 1 or type 2 diabetes, including people on insulin. It isn’t marketed as needle-free. Shine is the opposite: needle-free, glucose-only, aimed at adults not on insulin. Two breakthroughs, one direction.


Biolinq says it’s developing lactate and ketone sensing, though the cleared product covers glucose only. So the multi-marker patch is a “later,” not a “now.”


So, Are Fingersticks Over?


Not yet. And not for everyone.


If you’re an adult with type 2 diabetes, you don’t use insulin, and you want to see patterns, a needle-free patch could cut down on pokes. If you use insulin, you still need tools that give exact numbers, plus your care team’s guidance.

What I like is the direction: simpler sensors, less pain, more people paying attention. That’s good care design.


What Comes Next: Side-by-side comparison table of Shine and Libre Duo (rows: wear time, output, who it’s cleared for, needle-free or not).

So try this question this week: what would you change if you could watch your glucose react to dinner? Take the answer to your clinician.


FAQs


  1. Can teens or kids use these? 

    Shine is cleared for adults 22 and older. Libre Duo 10 Day is cleared for people age 2 and older with diabetes.


  2. Does Shine warn me about lows? 

    Coverage says it gives no numerical readings or alarms. It signals range with colors, so it isn’t a safety alert system.


  3. Is Libre Duo only for type 1 diabetes? 

    No. It’s cleared for type 1 or type 2, including people on insulin or SGLT2 inhibitors.


  4. Will insurance cover these? 

    I found no coverage details for Shine. Abbott says it’s working toward broad coverage for Libre Duo.


  5. Does a sensor replace my care team? 

    No. Biolinq describes Shine as supporting general awareness of patterns and trends, so use it to start better conversations.


Sources



Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before making health decisions, using wearable devices, or sharing personal medical data.


About the Author

Michelle Ryan, MHA, believes that everyone deserves access to quality healthcare and is committed to making that a reality. Whether it involves implementing new technologies to enhance patient care or developing policies that promote preventive health measures at BioLife Health Research Center, her goal is to create healthcare environments where patients feel supported, understood, and receive the best possible care.



Minds In Motion: High-Performance Training for an Age of Distraction


Minds in Motion goes beyond typical fitness books. It is a complete guide for anyone struggling to stay strong, focused, and resilient amid chronic stress and relentless distraction.


Authored by Dr. David Priede, PhD, with co-authors Lizbeth Kuruvilla and Cindy Hamilton, this book bridges cutting-edge brain science and practical, sustainable training.


Explore the architecture of human performance by integrating insights from neuroscience, psychology, sleep medicine, and behavioral science. It shows how mindful strength training reshapes the brain through neuroplasticity, intentional breathwork calms the nervous system, and sleep, nutrition, and recovery work together to build resilience in a fast-paced life.

bottom of page